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Abstract
Objectives—We evaluated the stability of the comorbidity between vulvodynia and orofacial 
pain (OFP) and its associated clinical characteristics over a two-year follow up period.
Methods—In an earlier study of vestibulodynia patients, we administered questionnaires 
assessing demographic data, self-reported pain, anxiety, somatic awareness, and presence of signs 
and symptoms suggestive of clinical and subclinical OFP. The present study readministered the 
same surveys to a subset of the original cohort after a two-year follow up period.
Results—Of the 138 women in the previous study, 71 (51%) agreed to participate in the present 
study. We confirmed our earlier findings that 1) orofacial pain is a highly prevalent (66%) 
condition among women with vestibulodynia, and 2) compared to women with no OFP symptoms, 
those with OFP symptoms experience higher levels of anxiety (P=0.005), and somatic awareness 
(P<0.001). While OFP symptoms showed improvement in many of the vestibulodynia patients 
(33%) with OFP symptoms at baseline, 13% had either developed new symptoms or transitioned 
from subclinical to clinical OFP classification. Intercourse-related pain decreased in 69% of 
patients and increased in 24% of patients. Consistent with our earlier report, we did not observe 
significant differences with respect to demographics or severity of pain during intercourse among 
the subgroups.
Discussion—Orofacial pain is a common comorbidity among women with vestibulodynia, 
although the presence of OFP can vary over time. The comborbidity between vestibulodynia and 
OFP suggests that common underlying mechanisms may mediate both conditions.
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Introduction
Vestibulodynia is the most common from of chronic vulvovaginal pain, which affects nearly 
1 in 10 women at some point in their lifetime.1 Vestibulodynia is also known as vulvar 
vestibulitis syndrome, localized vulvodynia, and, in 2004, was renamed as “provoked 
localized vulvodynia” by the International Society for the Study of Vulvovaginal Disease 
(ISSVD).2 However, the clinical diagnosis of vestibulodynia has not changed since its 
original inception by Friedrich in 1987.3 The diagnosis of vestibulodynia is a diagnosis of 
“exclusion” in that it is rendered only after excluding other “known causes” of persistent 
pain upon genital contact (i.e., tampon use) and tenderness to pressure localized within the 
vulvar mucosa (vestibule).3 To date, the etiology and natural history of vestibulodynia 
remain poorly understood.
Although the clinical definition of vestibulodynia is based on a peripheral conceptualization 
of the painful process, an emerging body of evidence supports the idea that vestibulodynia is 
a complex pain disorder of the urogenital region.4–6 In addition to higher pain sensitivity on 
mucosal contact, women with vestibulodynia show increased pain sensitivity in non-genital 
sites.6 A higher prevalence of psychological traits, such as somatic awareness and anxiety, 
are similarly documented in this population.7, 8 Collectively, these observations suggest that 
women with vestibulodynia may have an alteration in pain processing pathways similar to 
that seen in other pain disorders whereby certain psychosocial characteristics may facilitate 
the development and maintenance of a persistent pain state.8, 9
Granot and colleagues were the first to quantify the clinical implication of non-
gynecological characteristics of patients with vestibulodynia. 10–12They made an important 
observation that subgroups of women with vestibulodynia differed with respect to self-
reported anxiety, somatic awareness, and non-genital pain sensitivity.10–12 Women with 
higher non-genital pain sensitivity and anxiety tended to respond poorly to conventional 
treatments for vestibulodynia. 4 This work, as well as that of others,13–15 has led to a gradual 
shift away from the traditional conceptualization of vestibulodynia as primarily a local 
mucosal inflammatory process.
We hypothesize that vestibulodynia is a group of disorders characterized by peripheral 
nociceptive stimuli in the vestibular mucosa (e.g., heightened inflammatory response) and 
central pain processing pathways. However, the extent to which these dysfunctions 
contribute to the overall clinical picture varies among individuals. In our earlier work, we 
postulated that comorbidity with orofacial pain (OFP) might be a clinical marker for a state 
of pain amplification among women with vestibulodynia.8 We subsequently explored the 
prevalence and clinical characteristics of patients with vestibulodynia with or without 
comorbid OFP. Comorbid OFP was highly prevalent in our cohort of vestibulodynia 
patients.8 The objective of this study is to examine the stability of OFP symptoms two years 
after the initial examination and evaluate the association between our baseline observations 
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and the clinical correlates of comorbid OFP. We also evaluated the validity of our OFP 
diagnosis by having a sample of seven subjects undergo evaluation by an orofacial pain 
specialist.
Materials and Methods
This retrospective cohort questionnaire study was conducted in 2007, approximately two 
years following the initial evaluation. It was approved by the institutional review board at 
the University of North Carolina at Chapel Hill. Of the previously described cohort of 138 
women,8 seventy-five percent (n=103) had given permission to be contacted for future 
research. A package containing consent forms, study materials, and a pre-stamped envelope 
was mailed to potential participants. We received 13 packages marked “Return to Sender” 
from women who could not be contacted and did not receive anything from the remaining 
19 potential participants. Thus, our study sample consists of 71 women, representing 51% of 
the original cohort.
The battery of questionnaires included assessments for psychological characteristics and 
self-reported pain. Additionally, participants completed a 9-item, validated questionnaire in 
order to assess signs and symptoms suggestive of temporomandibular disorder (TMD).16 
Characteristics of these questionnaires are described below.
Pain Questionnaire
Self-reported pain with intercourse was assessed by administering the Gracely Pain Scale, 
which asks women to rate the lowest, average and maximal pain with intercourse on a scale 
of 0–100.17 Modified versions of this questionnaire are commonly used for assessing pain 
among patients with idiopathic pain disorders (e.g., TMD and fibromyalgia).
Psychological Questionnaires
We administered questionnaires to assess anxiety (Speilberger State-Trait Anxiety 
Inventory), somatic awareness (Pennebaker Inventory of Limbic Languidness), and global 
psychological distress (Brief Symptom Inventory-Global Severity Index). The following is a 
brief description of these questionnaires.
The State-Trait Anxiety Inventory (STAI) consists of two 20-item questionnaires, which 
assess an individual’s current anxiety level and general propensity towards anxiety. This 
instrument has good reliability (retest reliability: r=.73 to .86, Cronbach’s α=0.83 to 0.92) 
and is widely utilized in clinical research.18 The norm for a female population of 
comparable demographics is 36 on both scales. As a comparison, the average score of an 
inpatient neuropsychiatric population is 47.7 and 46.6, respectively for the state and trait 
anxiety scales.
The Pennebaker Inventory of Limbic Languidness (PILL)19 assesses somatization by 
capturing the frequency of occurrence of 54 common physical symptoms and sensations. It 
has high internal consistency (α=0.88) and adequate test-retest reliability (0.70 for a two-
month period); the norm for the female population is 98–104. 8, 19 A high PILL score is an 
independent risk factor for the development of a chronic pain state and is shown to correlate 
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well with the number of tender muscle sites, pain sensitivity and progression to 
chronicity. 20, 21
The Brief Symptom Inventory (BSI) consists of 53 items that evaluate psychological distress 
in nine areas: somatization, obsessive-compulsive, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. A global severity 
index (GSI) is obtained by combining the number and intensity of reported symptoms. 
Internal consistency using Cronbach’s α ranges from a low of 0.75 (psychoticism) to a high 
of 0.85 (depression). Test-retest validity for the global severity index score is 0.90.22
To examine the prevalence of signs and symptoms suggestive of idiopathic pain disorders in 
the orofacial region, we readministered a 9-item, validated screening questionnaire that 
queried the participants on the frequency and duration of symptoms such as headache, facial 
and jaw pain, grinding, and clenching. The same survey was previously administered at 
baseline and has been shown to have high sensitivity (100%) and specificity (81%) when 
used to screen for patients with TMD.8
Women were classified into one of three categories (OFP, subclinical OFP, or no OFP) by 
an independent reviewer who did not observe the subjects’ identification and responses to 
psychometric questionnaires.8 Participants were classified as having OFP if they had 
previously been diagnosed with TMD by a health care provider or reported experiencing 
both provoked and spontaneous orofacial pain and endorsed greater than three episodes of 
headache or “sinus pain” per week. Alternatively, they were classified as having subclinical 
OFP if they reported provoked orofacial pain and greater than three episodes of headache or 
“sinus pain” per week but no spontaneous orofacial pain. Subjects also had to report using a 
night guard, teeth grinding, or teeth clenching to be classified as having subclinical OFP. 
Three women were excluded from this analysis due to missing data.
Note: Although the questionnaire was designed to screen for TMD, we used the terms 
“OFP” and “subclinical OFP” rather than “TMD” and “subclinical TMD.” We used this 
terminology partly for consistency with the terminology in our earlier paper8 and partly out 
of concern that the term “TMD” usually implies that the diagnosis was based on a clinical 
exam rather than a questionnaire. Since no clinical exam was performed for the majority of 
the patients in the present study, we were concerned that using the term “TMD” could 
mislead readers. However, the expectation is that women in the OFP group will have TMD 
pain rather than other types of orofacial pain.
Finally, a random sample of 7 women from the original cohort agreed to undergo an 
independent assessment by an orofacial pain expert at our Regional Center for Neurosensory 
Disorders. Diagnoses were made by trained examiners using the Research Diagnostic 
Criteria for TMD classification.23 The examiners were trained and calibrated as part of the 
Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study. Calibration 
was repeated over 12–15 month intervals, and inter-examiner reliability was excellent. See 
Slade et al. (2011) 24 for details of the training and calibration procedure. The examiners 
were blinded to the participants’ questionnaire responses.
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Statistical analysis was performed using SAS version 9.1. The three OFP groups (OFP, 
subclinical OFP, no OFP) were compared with respect to each variable of interest. These 
characteristics include age, race, education, parity, marital status, duration of pain, and 
number of prior physicians seen for similar symptoms. Vestibulodynia-related pain and the 
psychological measures were also compared between the three groups. Also, the women 
who were retained in the cohort were compared with the women who were lost to follow up 
with respect to the demographic variables. The null hypothesis of no difference between the 
three groups was tested using Fisher’s exact test for categorical variables and one-way 
analysis of variance (ANOVA) for continuous variables. All tests comparing the three 
groups were conducted at α=0.05. If overall differences were detected (p<0.05), differences 
between the groups were evaluated using Bonferroni-adjusted t-tests.
The association between the psychological measures and changes in pain severity over time 
was also evaluated. First the women were dichotomized into two groups: those whose facial 
pain decreased from baseline to follow up (e.g., subclinical OFP became pain-free or OFP 
became subclinical OFP or pain-free) and those whose facial pain increased (e.g., subclinical 
OFP became OFP or pain-free became OFP or subclinical OFP). The null hypothesis of no 
difference between these two groups with respect to each psychological measure (measured 
both at baseline and at follow up) was evaluated using t-tests. Then the women were 
dichotomized into two groups again based on whether or not their average intercourse-
related pain rating decreased or increased from baseline to follow up and the analysis was 
repeated. Finally, the Pearson correlation between each psychological measure (measured 
both at baseline and follow up) and each rating of intercourse-related pain (measured at 
follow up) was calculated, and the null hypothesis that each correlation is equal to 0 was 
tested using linear regression.
Results
Among the 7 women who underwent an independent examination by an orofacial pain 
specialist, 5 were diagnosed with TMD. One of these five women was also diagnosed with 
fibromyalgia. The remaining two women did not meet the diagnostic criteria for TMD.
In general, participants were highly educated, Caucasian women in their early-to-mid-
thirties (Table 1). OFP symptoms were present in 66% (n=47) of the participants. Of those, 
49% (n=23) were classified as having subclinical OFP and 51% (n=24) were classified as 
having OFP. No significant demographic differences were observed among the subgroups, 
which was consistent with our earlier results. Only 7 women reported no intercourse-related 
pain. However, the average intercourse-related pain rating was significantly lower than it 
was in the original cohort (mean difference=18.0, p<0.0001). Also, no significant 
differences were observed between women retained in the cohort and women who were lost 
to follow up with respect to any of the demographic measures (Supplementary Table 1).
Similar to our earlier report, we observed significant differences in psychological 
characteristics among the three subgroups (Table 2). Compared to OFP-free patients with 
vestibulodynia, those with comorbid OFP had significantly higher levels of anxiety (STAI-
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state 36.6 vs. 44.8, p=0.025) and somatic awareness (PILL, 102.9 vs. 128.9, p=0.0007). 
Women with subclinical OFP scored somewhere in the middle of the range delineated 
between OFP and OFP-free. (Table 2) Also, self-reported severity of pain during intercourse 
did not differ among subgroups of women with OFP (average pain, 36.1 vs. 39.2, p=0.807).
Seventy-three percent (11/15) of OFP-free patients at baseline remained free of symptoms, 
whereas only 41% (9/22) and 53% (18/34) of vestibulodynia patients with subclinical and 
clinical OFP stayed within their respective category. (Table 3) Forty-three percent (24/56) of 
vestibulodynia patients with OFP symptoms at baseline showed reduced OFP symptoms at 
two-year follow-up. However, 27% (4/15) of OFP-free vestibulodynia patients developed 
new symptoms, and 23% (5/22) of patients with subclinical OFP transitioned to clinical OFP 
(n=5; 7%) classification by the time of the follow-up study.
No significant associations were observed between any of the psychological measures and 
improvement in either OFP or intercourse-related pain (Supplementary Table 2). In general 
no significant correlations were observed between the psychological measures at baseline 
and the intercourse-related pain levels at follow up (Supplementary Table 3). The 
psychological measures collected at follow up were generally positively correlated with 
intercourse-related pain, but (with a few exceptions) these correlations were not statistically 
significant.
Discussion
In our cohort 89% (61/68) of women with vestibulodynia reported at least some intercourse-
related pain at the time of follow up, and 65% (44/68) of these women had symptoms of 
orofacial pain. Similar to our earlier report, patients with comorbid OFP had higher levels of 
psychological distress. However, intercourse-related pain and demographic characteristics 
did not differ among the subgroups.
TMD is the most common form of chronic orofacial pain affecting upward of 10% of the 
adult population, and approximately 80% of the treated cases are women in their early-to-
mid-adulthood.24, 25 A previous study found that 49% of TMD patients showed complete 
remission after a five-year follow up period, and 23% reported a reduction in pain. 26 
Similarly, 43% of our cohort with OFP at baseline showed either improvement in symptoms 
(20%) or were OFP-free (23%) after two years. Thus, the trajectory of improvement in our 
cohort at 5 years is likely to be consistent with what has been reported in the literature. On 
the other hand, it is interesting to note that 16% (6/37) of women without OFP at baseline 
developed OFP during the two-year follow up period, which is much higher than the 
reported TMD incidence rate in the literature.27–29 The sample size in our cohort is 
relatively small, so this result should be interpreted cautiously. However, this suggests that 
not only is vestibulodynia comorbid with TMD but TMD-free women with vestibulodynia 
may be at higher risk of developing TMD.
The exact mechanism responsible for the association between musckeloskeletal pain of the 
orofacial region and provoked pain of the urogenital region is unknown.8 However, it is 
possible that a common underlying biological vulnerability may be a predisposing factor for 
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the genesis of pain in both conditions.8, 9, 30 Alternatively, a persistent pain state in women 
with vestibulodynia may predispose them to development of other idiopathic pain conditions 
such as fibromyalgia and/or TMD via central sensitization.6
Research in idiopathic pain disorders (e.g., TMD) requires conceptual models of the 
interplay between biological, psychological, and environmental factors and how these 
factors may ultimately affect the clinical phenotype of individuals with pain.9 Such a model 
is presently lacking in vestibulodynia. In the absence of such a multi-dimensional model, 
individual symptoms and characteristics are more likely to be misconstrued as “causal.” This 
follow up study provides confirmatory evidence of our baseline results suggesting that 
vestibulodynia is an idiopathic pain disorder that is comorbid with TMD.
A conceptual model for the development of TMD has been proposed wherein TMD (and 
other chronic pain conditions) are caused by a variety of genetic and environmental factors 
resulting in dysregulation in the central nervous system (CNS), which is manifested in the 
form of heightened pain sensitivity and psychological distress (Supplementary Figure 1).9, 25 
Note that this model implies a common set of risk factors for all idiopathic pain conditions. 
Thus, not only does the model predict that TMD will be comorbid with vestibulodynia but 
also that both TMD and vestibulodynia are comorbid with other common idiopathic pain 
conditions. Moreover, the model predicts that these common risk factors for idiopathic pain 
(namely heightened pain sensitivity and psychological distress) will be present in patients 
with TMD and vulvodynia (and other chronic pain conditions).
Consistent with our baseline results, we observed that a significant proportion of 
vestibulodynia patients had comorbid OFP and that patients with comorbid OFP have higher 
levels of psychological distress. Consistent with what has been observed elsewhere,31 the 
largest differences between OFP patients and patients without OFP were observed with 
respect to measures of somatic awareness (i.e., PILL and the somatization subscale of the 
BSI), with small differences apparent in measures of anxiety and depression. This is 
particularly noteworthy because psychological distress is associated with nearly all 
idiopathic pain disorders, and it may be caused by specific genetic variants that mediate the 
activities of central pain regulatory pathways.32 This study provides additional evidence in 
support of our earlier hypothesis that “… subgroups of women with vestibulodynia may 
share the same vulnerability as women with temporomandibular disorder. Thus, the 
associations between certain psychological traits and signs/symptoms of OFP among women 
with vestibulodynia suggest that an inherent susceptibility may permit or even precede the 
development of vestibulodynia in certain women.“ 8
It is interesting to note that several earlier studies have shown that vestibulodynia patients 
with high levels of psychological distress are more likely to report pain after a 
vestibulectomy.13, 14 This is consistent with the hypothesis that many forms of 
vestibulodynia are idiopathic pain conditions mediated by dysregulation in the CNS. If 
vestibulodynia is centrally mediated, patients will experience symptoms common to other 
idiopathic pain conditions (e.g., psychological distress). Moreover, treatments targeted at the 
vaginal region (e.g., vestibulectomy) are unlikely to be effective since they will not treat the 
CNS dysregulation that is truly responsible for the pain.
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While our results are interesting, it is important to note that our population primarily consists 
of patients with severe vestibulodynia that were recruited in a tertiary referral setting. 
Therefore, the findings from our patient population may not be generalizable. Furthermore, 
the 71 (out of the original cohort of 138) women who completed the 2-year follow up 
questionnaires may differ from those we were unable to reach. Nevertheless, it is unlikely 
that women who could not be reached would significantly change our findings because the 
associations between vulvodynia and OFP and between OFP and psychological distress 
remained nearly identical to our initial observation. Moreover, there were no significant 
demographic differences between the women who were retained in the cohort and the 
women who were lost to follow up.
Also, the sample size is relatively small, which limits the power to detect associations 
between variables of interest. In particular, the fact that no significant difference was 
observed between OFP and non-OFP women with respect to the anxiety and depression 
subscales of the BSI is most likely the result of insufficient power, since similar measures 
have been shown to be associated with TMD in larger studies.31 Similarly, the lack of a 
significant correlation between the psychological variables and intercourse-related pain and 
the lack of an association between the psychological measures and improvement in pain 
severity may also be the result of insufficient power. A similar study would need to be 
conducted with a larger sample to definitely answer the question of whether psychological 
distress is predictive of poorer treatment outcomes.
Another reason for caution when interpreting the results in Supplementary Table 3 is the fact 
that our cohort only includes women with vestibulodynia and thus is not representative of 
the general population. If pain-free women were included in our cohort, it is likely that these 
women would also have low levels of psychological distress, which might cause the 
correlation between psychological distress and intercourse-related pain to be significantly 
greater than 0. Thus, the lack of an association between psychological distress and 
intercourse-related pain in our cohort may imply that psychological distress is not associated 
with the severity of intercourse-related among women with vestibulodynia. However, if does 
not imply that psychological distress is not associated with the presence of intercourse-
related pain, because pain-free women were not included in our cohort.
Finally, it is worth noting that OFP was evaluated by questionnaire rather than a “gold 
standard” clinical exam. Although the questionnaire that was used has been shown to have 
excellent specificity and sensitivity for predicting examiner-verified TMD8 (and performed 
well in our small validation sample of 7 women), it is possible that some women were 
misdiagnosed.
Further confirmation of our hypothesis that vestibulodynia is a chronic condition mediated 
by dysregulation in the CNS would require recruiting additional women with vestibulodynia 
and evaluating them for the presence of TMD and other comorbid pain conditions. We are 
currently recruiting women for such a study and evaluating them both for the presence of 
TMD (and other idiopathic pain conditions) and for other measures known to be associated 
with idiopathic pain (such as measures of experimental pain sensitivity and psychological 
distress).
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Table 3
Diagnostic category of OFP*: baseline vs. 2 year follow-up (row %)
2 year follow-up
Diagnostic Category No OFP Subclinical OFP Clinical OFP
No OFP 11 (78.6%) 2 (14.3%) 1 (7.1%)
Subclinical OFP 8 (36.4%) 9 (40.9%) 5 (22.7%)
Clinical OFP 5 (14.7%) 11 (32.4%) 18 (52.9%)
*
OFP: Orofacial Pain
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